Obrist P - Search Results

1

An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer.

Schmidt M, Scheulen ME, Dittrich C, Obrist P, Marschner N, Dirix L, Schmidt M, Rüttinger D, Schuler M, Reinhardt C, Awada A. Schmidt M, et al. Among authors: obrist p. Ann Oncol. 2010 Feb;21(2):275-282. doi: 10.1093/annonc/mdp314. Epub 2009 Jul 24. Ann Oncol. 2010. PMID: 19633042 Free article. Clinical Trial.

2

Phase II study of the human anti-epithelial cell adhesion molecule antibody adecatumumab in prostate cancer patients with increasing serum levels of prostate-specific antigen after radical prostatectomy.

Marschner N, Rüttinger D, Zugmaier G, Nemere G, Lehmann J, Obrist P, Baeuerle PA, Wolf A, Schmidt M, Abrahamsson PA, Reinhardt C, Heidenreich A. Marschner N, et al. Among authors: obrist p. Urol Int. 2010;85(4):386-95. doi: 10.1159/000318055. Epub 2010 Jul 2. Urol Int. 2010. PMID: 20606402 Clinical Trial.

3

Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival.

Varga M, Obrist P, Schneeberger S, Mühlmann G, Felgel-Farnholz C, Fong D, Zitt M, Brunhuber T, Schäfer G, Gastl G, Spizzo G. Varga M, et al. Among authors: obrist p. Clin Cancer Res. 2004 May 1;10(9):3131-6. doi: 10.1158/1078-0432.ccr-03-0528. Clin Cancer Res. 2004. PMID: 15131054

4

Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer.

Spizzo G, Obrist P, Ensinger C, Theurl I, Dünser M, Ramoni A, Gunsilius E, Eibl G, Mikuz G, Gastl G. Spizzo G, et al. Among authors: obrist p. Int J Cancer. 2002 Apr 20;98(6):883-8. doi: 10.1002/ijc.10270. Int J Cancer. 2002. PMID: 11948467

5

Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.

Spizzo G, Went P, Dirnhofer S, Obrist P, Moch H, Baeuerle PA, Mueller-Holzner E, Marth C, Gastl G, Zeimet AG. Spizzo G, et al. Among authors: obrist p. Gynecol Oncol. 2006 Nov;103(2):483-8. doi: 10.1016/j.ygyno.2006.03.035. Epub 2006 May 6. Gynecol Oncol. 2006. PMID: 16678891

6

Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer.

Fong D, Moser P, Kasal A, Seeber A, Gastl G, Martowicz A, Wurm M, Mian C, Obrist P, Mazzoleni G, Spizzo G. Fong D, et al. Among authors: obrist p. Histopathology. 2014 Apr;64(5):683-92. doi: 10.1111/his.12307. Epub 2013 Dec 2. Histopathology. 2014. PMID: 24117877

7

Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer. A multicenter phase II trial (Gastric-2) of the Arbeitsgemeinschaft Medikamentose Tumortherapie (AGMT).

Wöll E, Greil R, Eisterer W, Bechter O, Fridrik MA, Grünberger B, Zabernigg A, Mayrbäurl B, Russ G, Dlaska M, Obrist P, Thaler J. Wöll E, et al. Among authors: obrist p. Anticancer Res. 2011 Dec;31(12):4439-43. Anticancer Res. 2011. PMID: 22199312 Clinical Trial.

8

EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis.

Spizzo G, Fong D, Wurm M, Ensinger C, Obrist P, Hofer C, Mazzoleni G, Gastl G, Went P. Spizzo G, et al. Among authors: obrist p. J Clin Pathol. 2011 May;64(5):415-20. doi: 10.1136/jcp.2011.090274. Epub 2011 Mar 17. J Clin Pathol. 2011. PMID: 21415054 Free PMC article.

9

High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer.

Spizzo G, Went P, Dirnhofer S, Obrist P, Simon R, Spichtin H, Maurer R, Metzger U, von Castelberg B, Bart R, Stopatschinskaya S, Köchli OR, Haas P, Mross F, Zuber M, Dietrich H, Bischoff S, Mirlacher M, Sauter G, Gastl G. Spizzo G, et al. Among authors: obrist p. Breast Cancer Res Treat. 2004 Aug;86(3):207-13. doi: 10.1023/B:BREA.0000036787.59816.01. Breast Cancer Res Treat. 2004. PMID: 15567937

10

EpCAM expression in squamous cell carcinoma of the oral cavity: frequency and relationship to clinicopathologic features.

Laimer K, Fong D, Gastl G, Obrist P, Kloss F, Tuli T, Gassner R, Rasse M, Norer B, Spizzo G. Laimer K, et al. Among authors: obrist p. Oral Oncol. 2008 Jan;44(1):72-7. doi: 10.1016/j.oraloncology.2007.01.008. Epub 2007 Apr 5. Oral Oncol. 2008. PMID: 17418618

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters